Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

DSM Venturing

Investor type Corporate Venture Capital


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Looking for a perfect list of funds?

Get recommendations from our smart algorithm

Get the list
Total investments 82
Average round size
The average size of a deal this fund participated in
Portfolio companies 60
Rounds per year 3.73
Lead investments 28
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 9
Key employees 6
Stages of investment
Early Stage Venture
Late Stage Venture

Areas of investment

  • Health Care
  • Biotechnology
  • Manufacturing
  • Medical Device
  • Wellness

DSM Venturing is the famous VC, which was founded in 1902. The leading representative office of defined VC is situated in the Urmond. The company was established in Europe in The Netherlands.

The usual things for fund are deals in the range of 5 - 10 millions dollars. This DSM Venturing works on 15 percentage points less the average amount of lead investments comparing to the other organizations. Speaking about the real fund results, this VC is 23 percentage points more often commits exit comparing to other organizations. The high activity for fund was in 2018. Despite it in 2019 the fund had an activity. The fund is constantly included in 2-6 investment rounds annually. The increased amount of exits for fund were in 2018.

For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Among the various public portfolio startups of the fund, we may underline Segetis, Verdezyne, Raycatch Besides, a startup needs to be aged 6-10 years to get the investment from the fund. The fund has no exact preference in a number of founders of portfolio startups. When startup sums 4 of the founder, the probability for it to get the investment is little. We can highlight the next thriving fund investment areas, such as Medical, Health Care.

Besides them, we counted 2 critical employees of this fund in our database.

The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the DSM Venturing, startups are often financed by BASF Venture Capital, Burrill & Company, Prelude Trust. The meaningful sponsors for the fund in investment in the same round are BASF Venture Capital, Burrill & Company, Prelude Trust. In the next rounds fund is usually obtained by Burrill & Company, BASF Venture Capital, Prelude Trust.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of DSM Venturing:
Typical Co-investors
DSM Venturing is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after DSM Venturing:

Funds with similar focus

Funds from The Netherlands
Funds with similar focus located in The Netherlands:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation


Food Processing
$14M21 Feb 2023 Leuven, Vlaams-Brabant, Belgium

Meala Foodtech

Food and Beverage
$1M08 Feb 2023 -

Miach Orthopaedics

Health Care
Medical Device
$30M25 Jan 2023 Boston, Massachusetts, United States

OK Capsule

Health Care
Life Science
$7M01 Jan 2023 Mill Valley, California, United States

Octarine Bio

Health Care
$2M20 Sep 2022 Copenhagen, Capital Region of Denmark, Denmark


Consumer Goods
Dietary Supplements
$6M15 Sep 2022 Palo Alto, California, United States


Developer APIs
Dietary Supplements
Health Care
Personal Health
$10M13 Sep 2022 Nashville, Tennessee, United States


Food and Beverage
$14M06 Jul 2022 Israel, North District, Israel

Chinova Bioworks

Food and Beverage
$6M23 Jun 2022 Fredericton, New Brunswick, Canada
Meatable Raises $47 Million Series A to Continue Scaling Trajectory and Expand its Product Portfolio with Beef

– Meatable has closed $47m in Series A funding.
– Consortium consists of Dr. Rick Klausner, Section 32, Dr. Jeffrey Leiden, and DSM Venturing.
– Existing investors, such as BlueYard Capital, Agronomics, Humboldt, and Taavet Hinrikus, show continued support.
– Meatable sees great potential in its technology and is betting on the company to solve the industry’s scalability and speed-to-market challenges with its patented opti-ox™ technology.
– Meatable aims to produce cultivated meat for which no animals are slaughtered, fewer GHG emissions are released, and less land and water are required.

Deep Branch Announces EUR 8M Series A Round led by Novo Holdings and DSM Venturing, Paving the Way for Commercial-Scale Production Facility

– Deep Branch has announced an €8M Series A round.
– The investment was led by Novo Holdings and DSM Venturing, with participation from Total Carbon Neutrality Ventures and Barclays Sustainable Impact Capital.
– Deep Branch addresses both the sustainability of animal farming and the reduction of carbon dioxide emissions with their CO2-to-protein technology, creating the first scalable path for a truly sustainable protein generation process from a waste product.
– The Series A financing will enable the completion of Deep Branch’s Scale-Up Hub at the Brightlands Chemelot Campus (Limburg, NL), producing the first pilot-scale batches of Proton™ for full nutritional validation with Europe’s leading feed producers, including BioMar and AB Agri.
– It will also enable the company to inform key engineering design work for its first commercial scale production facility.


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent DSM Venturing?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: